The combined administration of the intra-articular gene transfer of FasL with other genes and/or certain anti-inflammatory drugs might be an ideal complementary therapeutic approach for the local treatment of RA and other arthropathies. This evidence concerns the gene FASLG and rheumatoid arthritis.